Treatment of autoimmune diseases with antibodies to class II major histocompatibility complex antigens
- 31 October 1991
- journal article
- review article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 61 (1) , 1-17
- https://doi.org/10.1016/s0090-1229(06)80003-6
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- New perspectives on immunointervention in autoimmune diseasesImmunology Today, 1990
- Anti-class II β-chain antibodies in the serum and synovial fluid of rheumatoid arthritis patientsClinical Immunology and Immunopathology, 1990
- Experimental autoimmune thyroiditis in mice chronically treated from birth with anti-IgM antibodiesCellular Immunology, 1989
- SIDE EFFECTS AND IMMUNOGENICITY OF MURINE LYMPHOCYTE-SPECIFIC MONOCLONAL ANTIBODIES IN SUBHUMAN PRIMATESTransplantation, 1988
- INDUCTION OF SUPPRESSOR T CELLS BY INTRAVENOUS ADMINISTRATION OF MONOCLONAL ANTI-I-A ANTIBODYTransplantation, 1987
- Therapy of Autoimmune Diseases with Antibody to Immune Response Gene Products or to T‐Cell Surface MarkersaAnnals of the New York Academy of Sciences, 1986
- Prevention of experimental allergic encephalitis with in vivo administration of anti I-A antibody☆Decreased accumulation of radiolabelled lymph node cells in the central nervous systemJournal of Neuroimmunology, 1983
- Anti-Ia antibody in the sera of normal subjects after in vivo antigenic stimulation.The Journal of Experimental Medicine, 1982
- Mechanisms of regulation of cell-mediated immunity: Anti-I-A alloantisera interfere with induction and expression of T-cell-mediated immunity to cell-bound antigen in vivoClinical Immunology and Immunopathology, 1980
- Participation of suppressor T cells in the immunosuppressive activity of a heteroantiserum to human Ia-like antigens (p23,30).The Journal of Experimental Medicine, 1980